Related Experiment Videos
Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line
S P Fink1, S E Swinler, J D Lutterbaugh
1Howard Hughes Medical Institute, Case Western Reserve University and University Hospitals of Cleveland, Ohio 44106, USA.
Abstract:
Transforming growth factor-beta (TGF-beta) inhibits growth and induces apoptosis of colon epithelial cells. Binding of TGF-beta to its receptor induces phosphorylation of the Smad proteins Smad2 and Smad3, which then form heteromeric complexes with Smad4, translocate to the nucleus, and activate gene transcription. Smad4 function has been considered an obligate requirement for TGF-beta signaling, and Smad4 mutations present in some cancers have been considered sufficient to inactivate TGF-beta signaling. In this work, we describe studies with a nontransformed human colon epithelial cell line that is mutant for Smad4 but remains growth-inhibited by TGF-beta. The colon cell line VACO-235 has lost one of its Smad4 alleles via a chromosome 18q deletion. The remaining allele bears two missense point mutations located in regions important for Smad4 trimer formation, which is thought necessary for Smad4 function. As expected, pSBE4-BV/Luc, a Smad4-activated transcriptional reporter, was inactive in VACO-235. Nonetheless, VACO-235 demonstrated 80% growth inhibition in response to TGF-beta, as well as retention of some TGF-beta-mediated activation of the p3TP-Lux transcriptional reporter. Transient transfection of the VACO-235 Smad4 mutant allele into a Smad4-null cell line confirmed that this allele is functionally inactive as assayed by both the pSBE4-BV and p3TP-Lux reporters. The simplest explanation of these results is that there is a non-Smad4-dependent pathway for TGF-beta-mediated signaling and growth inhibition in VACO-235 cells.
Insights
Transforming growth factor-beta (TGF-beta) inhibits colon cell growth. Even with non-functional Smad4, colon cells show TGF-beta-induced growth inhibition, suggesting a non-Smad4 pathway exists.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Transforming growth factor-beta (TGF-beta) is known to inhibit colon epithelial cell growth and induce apoptosis.
- Smad4 is considered essential for TGF-beta signaling, with mutations linked to cancer progression.
- Smad4 mutations are typically thought to inactivate TGF-beta signaling pathways.
Purpose of the Study:
- To investigate TGF-beta signaling in colon epithelial cells with non-functional Smad4.
- To determine if Smad4 is absolutely required for TGF-beta-mediated growth inhibition in colon cancer cells.
- To explore potential non-Smad4 dependent pathways in TGF-beta signaling.
Main Methods:
- Utilized a human colon epithelial cell line (VACO-235) with Smad4 mutations.
- Assessed TGF-beta-induced growth inhibition and transcriptional reporter activity (pSBE4-BV/Luc and p3TP-Lux).
- Performed transient transfection experiments to confirm Smad4 allele inactivity.
Main Results:
- VACO-235 cells, despite Smad4 mutations, exhibited significant growth inhibition (80%) upon TGF-beta treatment.
- Partial TGF-beta-mediated activation of the p3TP-Lux reporter was observed in VACO-235 cells.
- The mutated Smad4 allele from VACO-235 was confirmed to be functionally inactive in a Smad4-null cell line.
Conclusions:
- A non-Smad4-dependent pathway for TGF-beta-mediated growth inhibition in colon epithelial cells is suggested.
- This finding challenges the established view of Smad4 as an obligate requirement for all TGF-beta signaling.
- Identifies a novel mechanism for TGF-beta action in colon cancer, potentially impacting therapeutic strategies.